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Abstract
Background: Data sparsity is a major limitation to estimating national and global dementia burden. Surveys with
full diagnostic evaluations of dementia prevalence are prohibitively resource-intensive in many settings. However,
validation samples from nationally representative surveys allow for the development of algorithms for the prediction
of dementia prevalence nationally.
Methods: Using cognitive testing data and data on functional limitations from Wave A (2001–2003) of the ADAMS
study (n = 744) and the 2000 wave of the HRS study (n = 6358) we estimated a two-dimensional item response theory
model to calculate cognition and function scores for all individuals over 70. Based on diagnostic information from the
formal clinical adjudication in ADAMS, we fit a logistic regression model for the classification of dementia status using
cognition and function scores and applied this algorithm to the full HRS sample to calculate dementia prevalence by
age and sex.
Results: Our algorithm had a cross-validated predictive accuracy of 88% (86–90), and an area under the curve of 0.97
(0.97–0.98) in ADAMS. Prevalence was higher in females than males and increased over age, with a prevalence of 4%
(3–4) in individuals 70–79, 11% (9–12) in individuals 80–89 years old, and 28% (22–35) in those 90 and older.
Conclusions: Our model had similar or better accuracy as compared to previously reviewed algorithms for the
prediction of dementia prevalence in HRS, while utilizing more flexible methods. These methods could be more easily
generalized and utilized to estimate dementia prevalence in other national surveys.
Keywords: Dementia, Prevalence, Algorithm, Validity, Global health
Background
High-quality estimates of dementia prevalence are
critical for informed health system planning, especially
given the high estimated prevalence of dementia, both
in the United States and globally. Recent estimates
*Correspondence: eln1@uw.edu
MPH, IHME, 3980 15th Ave. NE, Seattle, WA 98195, USA

suggest that there were an estimated 4.9 (95% UI 4.4–
5.4) million individuals living with dementia in the
United States and an estimated 51.6 (44.3–59.0) million individuals living with dementia globally in 2019
[1]. Policy- and decision-makers rely on these estimates
to inform public health planning efforts and resource
allocation decisions. One of the major limitations in the
estimation of dementia both nationally and globally is
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the lack of large, nationally representative surveys with
valid data on dementia prevalence using the Diagnostic
and Statistical Manual (DSM) definition [2, 3]. While
the lack of nationally representative data affects estimation even in high-income settings, due to the timeconsuming and costly nature of dementia assessments,
these limitations are especially problematic in lowincome countries, where there are large data gaps and
only few studies, mainly non-representative, exist [4, 5].
Many large-scale surveys, such as the Health and
Retirement Survey (HRS), a nationally representative sample of older adults in the United States, do not
include dementia diagnoses. However, the HRS and
other similar studies conduct evaluations of cognitive
ability and functional limitations, the two major determinants of dementia status [6]. The Aging, Demographics, and Memory Study (ADAMS) sampled individuals
from HRS and administered an intensive diagnostic
workup culminating in an adjudicated dementia diagnosis [7]. A number of algorithms have been developed
for the estimation of dementia prevalence in HRS based
on cut-points or regression-based methods using the
ADAMS subsample and the questions on demographic
information, cognitive status, and daily functional limitations that are included in both surveys [8–12]. This
study aimed to improve on these methods by using
multidimensional item response theory (IRT) methods
to more flexibly characterize cognitive status and functional limitations, potentially facilitating the use of similar strategies in other samples.
IRT methods are used to estimate ability on an unobserved (latent) trait [13]. While the latent trait is not
directly observed, answers to a series of questions (items)
are used to estimate ability (a measure of an individual’s
score on the latent trait) conditional on a given response
pattern. IRT methods account for variations in the difficulty in the items assessed as well as variations in the
strength of the relationship between different items and
the latent trait. Within the IRT framework, individuals who have the same sum score (count of total correct
items) can have different estimated latent cognitive abilities [14, 15].
If two different cognitive assessments have a subset
of items in common, these items can be used to co-calibrate the scales so that all available information can be
used and scores can be compared without sub-setting to
common items [16]. While previous applications of IRT
methods in epidemiology have largely focused on scoring
individuals on a single, unidimensional construct, such
as cognition, multidimensional IRT methods allow for
the concurrent estimation of multiple, related traits [17].
The DSM criteria for dementia are based on two different
but related latent traits: cognitive ability and functional
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(difficulty with completing daily activities) ability [18].
Therefore, a multidimensional analysis is required.
This study will improve on previous algorithms for
the prediction of dementia prevalence in HRS by utilizing IRT methods to more accurately capture the cognitive and functional abilities of participants. We will also
describe the potential utility of these methods for use
beyond the HRS and ADAMS samples, with a focus on
the benefits of their application to improve the global
estimation of dementia.

Methods
Sample description

The Health and Retirement Study (HRS) is a nationally
representative, prospective cohort study of over 37,000
individuals in the USA [6]. The study used data from the
2000 wave of the HRS survey. We excluded individuals
younger than 70 years old at this wave to ensure comparability between the HRS and ADAMS samples as
ADAMS was restricted to those 70 and older. The sample included 6373 individuals. The HRS study used proxy
respondents to assess cognition and function when individuals were unable to complete the survey themselves
(n = 1090).
The 2000 wave of HRS was used (along with the 2002
wave of HRS) as the sampling frame for the Aging,
Demographics, and Memory study (ADAMS). ADAMS
stratified the sampling process by age, sex, and cognitive status, sampling a larger number of individuals at
the lowest levels of cognitive performance [7]. The sample included 856 individuals. Proxy respondents for each
participant answered questions related to the participant’s cognitive abilities and functional limitations.
At least one non-missing response to survey items
is required for the estimation of ability on a latent trait.
We therefore excluded participants in both HRS and
ADAMS who did not have at least one valid response on
questions related to either cognition or functional limitations. In HRS, we excluded 5 individuals without data
on cognition and 10 individuals without data on functional limitations yielding a final sample size of 6358. In
ADAMS, we excluded 112 individuals without informant
reports, and therefore without a single valid response on
questions assessing functional limitations. Individuals
who were excluded were not significantly different from
those included in terms of their age, gender, years of education, or place of residence (nursing home vs. outside of
nursing home). This exclusion led to a final sample size of
744 individuals.
Cognitive and functional measures

HRS administered a reduced version of the Telephone
Interview for Cognitive Status (TICS), which includes
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immediate and delayed word recall tasks, the serial
7 s subtraction task, questions of orientation to time,
backwards counting, object naming, and naming the
president and vice president [19]. These were supplemented with additional questions on vocabulary from
the Wechsler Adult Intelligence Scale-revised (WAIS-R)
vocabulary test [20]. To assess function in HRS, respondents were asked a series of questions on activities of daily
living (ADLs) and instrumental activities of daily living
(IADLs), which are indicative not only of physical issues
but also difficulties in daily activities that may be influenced by cognition [21, 22]. When participants were
unable to answer cognitive questions, the short form of
Jorm’s Informant Questionnaire on Cognitive Decline in
the Elderly (IQCODE) was assessed (n = 660) [23].
The cognitive and functional items administered in
ADAMS additionally included the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) animal
fluency task [24], the Mini-Mental State Examination
(MMSE) [25], the three-trial CERAD word list [24], the
Trail Making Test Part A and B [26], the Digit Symbol
Substitution Test [27], and the Digit Span test [20]. A
full table of available items in each sample is available in
Additional File 1.
Dementia adjudication

All participants in ADAMS were evaluated by a nurse
and neuropsychology technician in a 3–4 h structured
interview and assessment. A team of clinicians from the
ADAMS study, including the study geropsychiatrist, neurologist, neuropsychologist, and cognitive neuroscientist,
assigned clinical dementia diagnoses in ADAMS based
on all information collected along with available medical records [28]. Diagnoses were based on DSM-III-R and
DSM-IV criteria.
Statistical analysis

The overall analytic strategy used in this analysis is
described in Fig. 1. We first calculated descriptive
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statistics to compare the HRS and ADAMS samples. We
used IRT methods to estimate models for latent cognitive and functional ability in both HRS and ADAMS.
Items with continuous outcomes were discretized using
ten category equal-interval discretization [29]. We collapsed categories until all categories contained at least
5% of the total sample to prevent instability.
Based on our a priori knowledge and the results of
exploratory factor analysis models (additional details in
Additional File 1), we selected a two-factor model and
designated items as related to either a factor describing cognition or a factor describing physical function
(full list in Additional File 1). We then estimated a multiple group two-factor IRT model using the ADAMS
and HRS samples, allowing for correlation between
the two factors. Within the IRT model, binary items
were modelled using two-parameter logistic regression
models, and ordered polytomous items were modelled
using graded-response models [30]. In IRT models,
individual records are assumed to be independent of
each other. Therefore, individuals appearing in both the
HRS 2000 wave and the ADAMS sample were excluded
from the HRS sample in this model (n = 773) to ensure
that only one record per individual was retained in the
final model. Item parameters (loadings and thresholds) were estimated using maximum likelihood, and
parameter values on items that were shared between
the samples were constrained to be equal. Item loadings are a measure of the relationship between the
item and the underlying latent trait on a scale of 0–1,
whereas item thresholds indicate the ability level at
which 50% of individuals correctly answered a binary
item or endorsed a given response option for an ordinal item. We excluded items with loadings of less than
0.3, as this indicates a poor relationship with the underlying latent factor (n = 3 items). We calculated omega
as a measure of the internal reliability of each of the
factors estimated in our multidimensional IRT model
using previously described methods [31]. Based on this

Fig. 1 Flowchart for the estimation procedure. Data from the Health and Retirement Study (HRS) and the Aging, Demographics, and Memory
study (ADAMS) are used in a multidimensional item response theory model to calculate factor scores of cognition and function. These factor scores,
together with demographic information are then utilized in a logistic regression model to predict dementia status. This algorithm is then used to
assess prevalence in HRS and model accuracy is assessed using ADAMS
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model, we estimated factor scores for all participants in
the two samples.
We then estimated three weighted logistic regression
models to predict dementia status in the ADAMS sample accounting for the complex survey design. Our first
model (base model) included only age and sex as predictors of dementia status, whereas the second model (factor
score model) included only the factor scores for cognition and function. The final model (full model) included
age and sex as well as the two factor scores. We compared models using the Akaike Information Criterion
(AIC) and likelihood ratio tests and tested model calibration using the Hosmer–Lemeshow goodness of fit test.
We evaluated model discrimination and performance
using ten-fold cross validation in the ADAMS sample,
and we calculated cross-validated area under the curve
(AUC), sensitivity, specificity, and accuracy, defined as
the proportion of individuals who were correctly classified. To derive 95% uncertainty intervals around model
performance metrics, we sampled 1000 draws of predictions from our logistic regression model, accounting
for uncertainty in the estimated model parameters. We
then calculated performance metrics for each draw and
then defined the 95% confidence interval as the 25th and
975th value of the ordered draw.
We then used the full model to predict dementia status
in HRS, defining dementia as having a predicted probability greater than 0.5. To estimate dementia prevalence
in HRS, we used survey weights to calculate weighted
means and estimated confidence intervals accounting for
the complex survey design and the variance in the sampling strategy. Statistical analysis was conducted in R,
and IRT models were estimated using the mirt package
[32]. R code is available via https://github.com/ihmeuw.

Results
Sample characteristics

The ADAMS and HRS samples both included more
women than men; however, the ADAMS sample was
slightly older (mean age in years; standard deviation
[SD]: 81.5; 7.1) than the HRS sample (77.8; 5.8). ADAMS
oversampled individuals with higher levels of cognitive
impairment, and this is reflected in the lower scores on
the TICS cognitive assessment, higher mean number of
ADL limitations, and lower levels of education as compared to the HRS sample (Table 1).
IRT harmonization model

The estimated reliability coefficients for the cognition
and functional limitations factors based on the multiple-group two-factor IRT model were 0.52 and 0.86
respectively. This indicates good reliability for the function scale, but points to the existence of some remaining
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Table 1 Study characteristics comparing the Health and
Retirement Survey (HRS) with the Aging, Demographics and
Memory Study (ADAMS)
HRS (N = 6358) ADAMS (N = 744)
Age: 70–79—%

70.6

Age: 80–89—%

26.6

46.8
42.1

Age: 90 + —%

2.8

11.2

Education (Less than HS)—%

34.3

50.7

Education (HS)—%

33.8

24.1

Education (More than HS)—%

31.9

25.3

Sex (Female)—%

58.2

57.9

Nursing home status (Yes)—%

0.3

9.7

TICS score—mean (SD)

9.3 (1.2)

6.8 (3.3)

Number of ADL limitations—
mean (SD)

0.7 (1.3)

1.5 (2.2)

SD standard deviation, HS high school, TICS telephone Interview for cognitive
status (score 0–10, with 10 being highest cognition), ADL activities of daily living
(score 0–6, with 6 being needs the most help)

unexplained variation in the items included in the cognition factor.
The estimated loadings among the cognitive items
ranged from 0.34 to 0.88. The items with the highest loadings were the MMSE items for naming a wristwatch, pencil, and the current year as well as the Digit
Symbol Substitution Test. The loadings for the items
assessing functional limitations were on average higher,
ranging from 0.70 to 0.93. The items with the highest
loadings were from the IQCODE proxy questionnaire
and included the questions about whether the individual
knew how to work familiar machines, and knew how to
handle money and shop (Fig. 2; Panel A).
The estimated thresholds for cognition ranged
from − 3.1 to 6.7 logits (on the scale of the latent trait)
and covered the range of estimated factor scores for
cognition (estimates of cognitive ability). There were a
larger number of thresholds below the mean of the distribution of cognition factor scores, indicating that the
questions administered were better able to precisely estimate cognition for individuals with lower levels of cognitive ability. The distribution of estimated thresholds
for functional limitations was bimodal. Items assessing
ADLs, IADLs, and informant reports of whether individuals declined versus retained the ability to perform a
task as compared to two years ago had estimated thresholds between − 1.81 and − 0.76 logits. The second mode
of thresholds spanned 1.39–1.87 logits and consisted of
the informant report thresholds for whether participants
improved over the last two years on everyday tasks. These
thresholds correspond to a higher ability level because
improving function is more difficult than preventing
functional decline. The distribution of ability estimates
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was left-skewed, indicating that while a substantial proportion of the population did not have functional limitations, a smaller subset had a larger burden of functional
limitations (Fig. 2; Panel B).
Dementia prevalence prediction

Fig. 2 Distribution of parameters from the multidimensional item
response theory model linking estimates of latent cognitive and
functional ability in the Health and Retirement Study (HRS) and the
Aging, Demographics, and Memory study (ADAMS). Panel (A) shows
the distribution of item loadings. The item loadings indicate the
strength of the relationship between each item and the latent trait
on a scale of 0–1. Panel (B) shows the distribution of item thresholds
and the density distribution of estimated individual-level latent
cognitive and functional abilities from the two samples overlaid in
blue. Thresholds indicate either the difficulty of a binary item or the
difficulty of scoring one category higher on an ordinal item. A higher
number of thresholds at a given estimated ability level indicates
higher precision for the estimation of the latent trait at that ability
level

The base model, predicting dementia status based on only
age and sex, indicated that for each additional year of age,
the odds of having dementia increased by 17% (95% UI
13–21). The factor score model indicated that the cognition and functional limitations each strongly predicted
dementia status. For each unit increase in latent cognitive
ability (a unit is one standard deviation of ability in the
ADAMS sample), there was a 97% (94–98) reduction in
the odds of having dementia, and for each unit increase
in latent functional ability, there was a 57% (13–79)
reduction in the odds of having dementia. When adjusting for age and sex in the full model, the coefficient estimates for the factor scores did not substantially change.
However, the effect size for age was greatly diminished.
AIC was lowest for the model that only included factor
scores, and a likelihood ratio test of nested models indicated that age and sex did not improve the model once
the cognitive and functional ability were accounted for
(Table 2). However, we retained age and sex in our final
model, because of their biological link to dementia status.
The Hosmer–Lemeshow goodness of fit test indicated
good calibration (P = 0.48) and the cross-validated area
under the curve for this final model was 0.97 (0.97–0.98),
indicating excellent discrimination. Based on ten-fold
cross-validation in the ADAMS sample, the sensitivity of
predictions from this model was 84% (80–87), the specificity of the predictions was 90% (88–92), and the overall
predictive accuracy of the model was 88% (86–90).
The distributions of factor scores by dementia status
were similar whether classifying dementia based on true
dementia status or predicted dementia status, indicating that the algorithm correctly classified most individuals. The distributions of estimated cognitive ability in the
HRS sample were largely non-overlapping when comparing those classified as having versus not having dementia, indicating that the algorithm discriminates strongly

Table 2 Odds ratios for the classification of dementia status in the Aging, Demographics, and Memory study (ADAMS)
Base model

Factor score model

Full model

Age (per year)

1.17 (1.13–1.21)

1.02 (0.97–1.07)

Sex (female vs. male)

1.33 (0.83–2.14)

1.37 (0.61–3.07)

Cognition factor (per SD)

0.03 (0.02–0.06)

0.03 (0.02–0.06)

Functional limitations factor (per SD)

0.43 (0.21–0.87)

0.46 (0.23–0.92)

129.815

133.16

AIC

389.705

Odds ratios are from logistic regression models, Intervals represent 95% confidence intervals
AIC alkaike information criterion

GBD 2019 Dementia Collaborators BMC Med Inform Decis Mak

(2021) 21:241

Page 6 of 10

on cognitive status. The overlap in the distributions was
greater for functional ability as compared to cognition,
due to the lack of specificity of general functional loss
(Fig. 3).
Based on the results of this model and factor scores
estimated from the HRS sample, we estimated that the
overall prevalence of dementia in the United States over
the age of 70 was 7% (95% UI 6–7). The prevalence was
higher in females than males, and prevalence increased
with age, with an estimated prevalence of 4% (3–4) in
individuals 70–79 years old, 11% (9–12) in individuals
80–89 years old, and 28% (22–35) in individuals 90 years
old and older (Fig. 4).

Discussion
Our algorithm had good discrimination for the classification of dementia status, with an area under the curve
of 0.97 (95% UI 0.97–0.98). The model correctly classified 88% (86–90) of individuals in ADAMS, and based on
the application of this model to the HRS sample, we predicted that in 2000, the prevalence of dementia over age
70 was 7% (95% UI 6–7).

Fig. 3 The distributions of latent cognitive and functional ability by
dementia status in the Aging, Demographics, and Memory study
(ADAMS) and the Health and Retirement Survey (HRS). The three
plots show three different forms of dementia status: ADAMS true
prevalence refers to dementia status based on the adjudicated
clinician-based assessment, ADAMS predicted prevalence refers to
dementia status in ADAMS based on the item response theory (IRT)
algorithmic approach, and HRS predicted prevalence refers to the
results of the IRT algorithmic approach in HRS

Fig. 4 Predictions of dementia prevalence in the United States in
2000 by age and sex. These estimates were based on the application
of the model developed in ADAMS to the Health and Retirement
Study (HRS)

In our algorithmic logistic regression models, the
strong and significant effect of age was highly attenuated after accounting for cognition and functional
limitations. This suggests that the effect of age was
explained by the observed variation in cognition and
functional limitations. Although the effect of female sex
was not statistically significant, our models suggested a
higher odds of dementia in women compared to men
and the estimated effect size was similar to what has
been previously reported in ADAMS [33].
Compared to the five algorithms reviewed in Gianattasio and colleagues (2019) and evaluated using validation data, our algorithm had the highest sensitivity,
the fourth highest specificity, and the highest AUC of
the regression-based algorithms [34]. Our algorithm
had the same accuracy as the top-performing algorithm reviewed (the Hurd et al. algorithm, accuracy:
88%; 85–91), but this algorithm requires data on cognition from a previous wave of HRS, whereas our algorithm leverages only cross-sectional data, increasing its
potential applications to settings where no longitudinal data are available [10, 34]. More recent algorithms
developed with ADAMS data for use in the HRS have
been shown to have similar performance as compared
our algorithm in terms of sensitivity, specificity and
accuracy [35]. However, our IRT-based algorithm provides a more flexible framework for algorithm development that can be leveraged to estimate prevalence in
other aging surveys.
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Compared to prevalence estimates from previously
derived algorithms, the HRS prevalence estimates by
age group derived from our algorithm (70–79 years old:
4%; 3–4, 80–89 years old: 11%; 9–12, 90+ years old: 28%;
22–35) are higher than those calculated using the Herzog-Wallace cutoffs (70–79 years old: 2%, 80–89 years
old: 8%, 90+ years old: 16%) but lower than those calculated using the Langa-Weir cutoffs (70–79 years old:
8%, 80–89 years old: 20%, 90+ years old: 45%) [9]. When
compared to other studies, our age-specific estimates
are higher than what has been observed in the Framingham Heart Study (70–79 years old: 3%, 80–93 years old:
16%); but lower than what has been observed in the Atherosclerosis Risk in Communities Study (70–74 years
old: 5%, 75–79 years old: 9%, 80–84 years old: 15%,
85–89 years old: 25%); differences between these estimates and estimates from cohort studies could be due
to a number of factors including differences between the
population under study and the US population as a whole
[36, 37]. Our estimates are similar to what has been previously reported based on 2008 Medicare records (65–
74 years old: 3%, 75–84 years old: 10%; 85+ years old:
25%) but lower than what was previously reported based
only on the ADAMS subsample (70–79 years old: 5%,
80–89 years old: 24%; 9–12, 90+ years old: 37%; 22–35)
[33, 38]. However, the estimates from the ADAMS sample may be biased due to the low response rate (56%) if
the estimated survey weights were unable to fully correct
for the patterns of non-response observed [28].
There were a number of limitations to this work. First,
in ADAMS, all items on functional limitations were asked
of a proxy informant, whereas items on ADLs and IADLs
in HRS were administered to a proxy respondent only if
the participant was unable to be interviewed. To harmonize the data on functional limitations, we assumed there
would not be differences in response patterns of respondents and proxy respondents for individuals who did not
have a proxy respondent in HRS as well as individuals in
ADAMS who would not have needed a proxy respondent had they completed the HRS survey at that time.
Previous evidence has suggested reasonable concordance between proxy-reported and self-reported activities of daily living [39, 40]. Second, while IRT methods
allow for the inclusion of individuals with some missing
data, we assume that among individuals who were able to
complete at least some of the cognitive testing, items are
missing at random [41]. However, this assumption would
be violated if individuals were more likely to have missing
data on the cognitive tests that were most difficult. Third,
differences between the ADAMS and HRS samples
could influence the performance of our algorithm, which
we developed using the ADAMS sample but applied to
the HRS sample. Although ADAMS participants were
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sampled from HRS, they were on average older and less
well educated compared to the full HRS sample. Third,
the response rate among individuals selected for the
ADAMS sample was 56%, and this selection bias may
have affected algorithm development. Although we were
unable to validate our algorithm in the HRS, future work
linking HRS participants with another source of information such as medical claims data would help validate the
performance of the algorithm in the HRS sample. Fourth,
this algorithm was developed for the purposes of overall
prevalence estimation without regard to potential discrepancies by subgroups such as racial and ethnic categories. As previous work has identified biases in algorithms
by racial and ethnic subgroups, this algorithm should
not be applied to the study of racial subgroups without
further modification [34]. Additionally, changes in the
racial and ethnic composition of the US population over
time may influence algorithm performance in more modern samples without algorithm re-calibration. While the
ADAMS sample is a great resource for algorithm development, the sample is now 20 years old. However, the
methodology developed could be used to re-calibrate the
algorithm given a more current data source.
Although this algorithm is more complex than those
previously developed, it is not reliant on having complete
overlap in the items assessing cognition and function.
Instead, all available items in both surveys can be utilized,
provided there is sufficient overlap to “anchor” the scale
and link scores between samples. Extending beyond the
HRS sample, if a survey in another country had sufficient
overlap with ADAMS on items assessing cognition and
function, the ADAMS sample and the methods utilized
here could be leveraged to provide prevalence estimates
for surveys in other locations [14]. A number of countries (e.g., South Africa) do not have formal evaluations
of dementia prevalence available but have conducted
broader surveys which include evaluations of cognition and functional limitations [42]. The application of
these methods to available surveys could therefore help
address issues of data sparsity in the global modelling
of dementia prevalence. The simplicity of the proposed
algorithm, which only includes basic demographic variables in addition to cognition and functional limitations,
facilitates the potential generalization of this method to
the estimation of prevalence in other geographic settings.
By improving data coverage and the quality of global estimates for dementia prevalence, decision-makers and policy-makers will be able to make better evidence-driven
decisions around resource allocation and funding.
However, when harmonizing measures of cognition
and function in the ADAMS sample with samples outside of the United Sates, it will be important to consider
potential implications of differential item functioning
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(DIF), or differences across cultural contexts in estimated item parameters. Prior work showing evidence of
DIF in cognitive items by demographic characteristics
suggests that differences in cultural contexts will likely
lead to some DIF, which could result in biased comparisons between samples. However, if some common items
without evidence of DIF can be identified, models can
be adjusted to account for DIF [43–45]. Use of smaller
validation samples nested in larger surveys, such as the
proposed validation sample to be conducted within the
Longitudinal Aging Study in India, would allow for context-specific algorithm calibration and would circumnavigate potential concerns about DIF [46].

Conclusions
In summary, we used multidimensional IRT-based methods to predict prevalence in the HRS sample. Compared
to previous algorithms, our model had similar or better
accuracy in the ADAMS sample. Furthermore, because
the algorithm only relies on having a subset of items in
common with a validation sample, this strategy could
potentially be extended to other contexts. By improving
the overall accuracy of predictive algorithms and potentially allowing researchers to leverage new data sources,
this algorithmic strategy could serve to strengthen
national and global estimates of dementia and improve
the evidence on which policy-makers can base important
decisions surrounding public health planning efforts and
the resource allocation.
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